Scholarlink

<p>Subjective cognitive symptoms (brain fog, memory problems) are common in menopause, but whether these self-reported symptoms correspond to measurable deficits in cognition remains unclear. In 14,234 females (aged 45–55) from the REACT-Long Covid Study, we examined self-reported cognitive symptoms and objective cognitive performance in premenopausal, perimenopausal, postmenopausal participants. Global cognitive performance was derived from eight online tasks (‘Cognitron’). Perimenopausal (OR = 1.31 [1.18, 1.35], <i>p</i> = 0.015) and postmenopausal participants (OR = 1.13 [1.08, 1.32], <i>p</i> = 0.014) had higher odds of reporting cognitive symptoms than premenopausal participants. Objective cognitive performance differed minimally across menopause status groups, with perimenopausal participants showing marginally higher accuracy than premenopausal and postmenopausal participants (0.03–0.06 SD, <i>p</i> &lt; 0.023). Across all menopause status groups, cognitive symptoms were weakly associated with objective performance but moderately related to psychological symptoms. These findings underscore recognising cognitive symptoms as a key component of menopausal care and integrating patient-reported outcomes with objective and biological measures of cognitive health.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Cognition and the menopause transition: cross-sectional evidence from a large community cohort

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月16日

查看全文
  • Laura F. Naysmith,
  • Helen Ward,
  • Paul Elliott,
  • Christina Atchison,
  • Peter Hellyer,
  • Peter Denno,
  • Steven C. R. Williams,
  • Adam Hampshire

摘要

Subjective cognitive symptoms (brain fog, memory problems) are common in menopause, but whether these self-reported symptoms correspond to measurable deficits in cognition remains unclear. In 14,234 females (aged 45–55) from the REACT-Long Covid Study, we examined self-reported cognitive symptoms and objective cognitive performance in premenopausal, perimenopausal, postmenopausal participants. Global cognitive performance was derived from eight online tasks (‘Cognitron’). Perimenopausal (OR = 1.31 [1.18, 1.35], p = 0.015) and postmenopausal participants (OR = 1.13 [1.08, 1.32], p = 0.014) had higher odds of reporting cognitive symptoms than premenopausal participants. Objective cognitive performance differed minimally across menopause status groups, with perimenopausal participants showing marginally higher accuracy than premenopausal and postmenopausal participants (0.03–0.06 SD, p < 0.023). Across all menopause status groups, cognitive symptoms were weakly associated with objective performance but moderately related to psychological symptoms. These findings underscore recognising cognitive symptoms as a key component of menopausal care and integrating patient-reported outcomes with objective and biological measures of cognitive health.